Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection

Masayoshi Shinjo(H), Yaoko Takano, Takao Takahashi, Naoki Hasegawa, Satoshi Iwata, Norio Sugaya

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

BACKGROUND: Postexposure prophylaxis (PEP) using neuraminidase inhibitors against exposure to influenza virus has been well studied in household settings but not in nosocomial settings in pediatric wards. METHODS: We used oseltamivir or zanamivir as PEP in our pediatric wards. All influenza cases were diagnosed by the influenza rapid diagnostic test. RESULTS: Between 2003 and 2011, there were 20 nosocomial introductions of influenza (10 were A, 9 were B and 1 was undetermined). The index cases consisted of 17 inpatients, 2 parents and 1 medical staff member. The 17 inpatients had been admitted to the hospital for reasons other than infectious disease and they developed influenza after hospitalization. Among the 81 contacts, 28 (35%) were exposed to influenza A, and 52 (64%) were exposed to influenza B. The rate of secondary infection among contacts not given PEP was 29% (5/17), and the rate among contacts given PEP was significantly lower, 3% (2/63; P = 0.004). The 2 infected contacts who had been given PEP were both influenza B cases, and both had received oseltamivir. The contacts who received PEP within 24 hours (59), for influenza A (23) and those who received zanamivir (15) did not develop influenza. No adverse events were reported. CONCLUSIONS: PEP using oseltamivir or zanamivir for unexpected occurrences of nosocomial influenza in pediatric wards is safe and effective. The influenza rapid diagnostic test that we used was helpful for detecting nosocomial influenza in children.

Original languageEnglish
Pages (from-to)1119-1123
Number of pages5
JournalPediatric Infectious Disease Journal
Volume31
Issue number11
DOIs
Publication statusPublished - 2012 Nov

Fingerprint

Zanamivir
Oseltamivir
Human Influenza
Pediatrics
Antigens
Routine Diagnostic Tests
Inpatients
Medical Staff
Neuraminidase
Orthomyxoviridae
Coinfection
Communicable Diseases

Keywords

  • influenza virus
  • oseltamivir
  • pediatric
  • postexposure prophylaxis
  • zanamivir

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Infectious Diseases
  • Microbiology (medical)

Cite this

Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection. / Shinjo(H), Masayoshi; Takano, Yaoko; Takahashi, Takao; Hasegawa, Naoki; Iwata, Satoshi; Sugaya, Norio.

In: Pediatric Infectious Disease Journal, Vol. 31, No. 11, 11.2012, p. 1119-1123.

Research output: Contribution to journalArticle

@article{56a6f28afc3d485c9ea53c5def60add2,
title = "Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection",
abstract = "BACKGROUND: Postexposure prophylaxis (PEP) using neuraminidase inhibitors against exposure to influenza virus has been well studied in household settings but not in nosocomial settings in pediatric wards. METHODS: We used oseltamivir or zanamivir as PEP in our pediatric wards. All influenza cases were diagnosed by the influenza rapid diagnostic test. RESULTS: Between 2003 and 2011, there were 20 nosocomial introductions of influenza (10 were A, 9 were B and 1 was undetermined). The index cases consisted of 17 inpatients, 2 parents and 1 medical staff member. The 17 inpatients had been admitted to the hospital for reasons other than infectious disease and they developed influenza after hospitalization. Among the 81 contacts, 28 (35{\%}) were exposed to influenza A, and 52 (64{\%}) were exposed to influenza B. The rate of secondary infection among contacts not given PEP was 29{\%} (5/17), and the rate among contacts given PEP was significantly lower, 3{\%} (2/63; P = 0.004). The 2 infected contacts who had been given PEP were both influenza B cases, and both had received oseltamivir. The contacts who received PEP within 24 hours (59), for influenza A (23) and those who received zanamivir (15) did not develop influenza. No adverse events were reported. CONCLUSIONS: PEP using oseltamivir or zanamivir for unexpected occurrences of nosocomial influenza in pediatric wards is safe and effective. The influenza rapid diagnostic test that we used was helpful for detecting nosocomial influenza in children.",
keywords = "influenza virus, oseltamivir, pediatric, postexposure prophylaxis, zanamivir",
author = "Masayoshi Shinjo(H) and Yaoko Takano and Takao Takahashi and Naoki Hasegawa and Satoshi Iwata and Norio Sugaya",
year = "2012",
month = "11",
doi = "10.1097/INF.0b013e318260265a",
language = "English",
volume = "31",
pages = "1119--1123",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection

AU - Shinjo(H), Masayoshi

AU - Takano, Yaoko

AU - Takahashi, Takao

AU - Hasegawa, Naoki

AU - Iwata, Satoshi

AU - Sugaya, Norio

PY - 2012/11

Y1 - 2012/11

N2 - BACKGROUND: Postexposure prophylaxis (PEP) using neuraminidase inhibitors against exposure to influenza virus has been well studied in household settings but not in nosocomial settings in pediatric wards. METHODS: We used oseltamivir or zanamivir as PEP in our pediatric wards. All influenza cases were diagnosed by the influenza rapid diagnostic test. RESULTS: Between 2003 and 2011, there were 20 nosocomial introductions of influenza (10 were A, 9 were B and 1 was undetermined). The index cases consisted of 17 inpatients, 2 parents and 1 medical staff member. The 17 inpatients had been admitted to the hospital for reasons other than infectious disease and they developed influenza after hospitalization. Among the 81 contacts, 28 (35%) were exposed to influenza A, and 52 (64%) were exposed to influenza B. The rate of secondary infection among contacts not given PEP was 29% (5/17), and the rate among contacts given PEP was significantly lower, 3% (2/63; P = 0.004). The 2 infected contacts who had been given PEP were both influenza B cases, and both had received oseltamivir. The contacts who received PEP within 24 hours (59), for influenza A (23) and those who received zanamivir (15) did not develop influenza. No adverse events were reported. CONCLUSIONS: PEP using oseltamivir or zanamivir for unexpected occurrences of nosocomial influenza in pediatric wards is safe and effective. The influenza rapid diagnostic test that we used was helpful for detecting nosocomial influenza in children.

AB - BACKGROUND: Postexposure prophylaxis (PEP) using neuraminidase inhibitors against exposure to influenza virus has been well studied in household settings but not in nosocomial settings in pediatric wards. METHODS: We used oseltamivir or zanamivir as PEP in our pediatric wards. All influenza cases were diagnosed by the influenza rapid diagnostic test. RESULTS: Between 2003 and 2011, there were 20 nosocomial introductions of influenza (10 were A, 9 were B and 1 was undetermined). The index cases consisted of 17 inpatients, 2 parents and 1 medical staff member. The 17 inpatients had been admitted to the hospital for reasons other than infectious disease and they developed influenza after hospitalization. Among the 81 contacts, 28 (35%) were exposed to influenza A, and 52 (64%) were exposed to influenza B. The rate of secondary infection among contacts not given PEP was 29% (5/17), and the rate among contacts given PEP was significantly lower, 3% (2/63; P = 0.004). The 2 infected contacts who had been given PEP were both influenza B cases, and both had received oseltamivir. The contacts who received PEP within 24 hours (59), for influenza A (23) and those who received zanamivir (15) did not develop influenza. No adverse events were reported. CONCLUSIONS: PEP using oseltamivir or zanamivir for unexpected occurrences of nosocomial influenza in pediatric wards is safe and effective. The influenza rapid diagnostic test that we used was helpful for detecting nosocomial influenza in children.

KW - influenza virus

KW - oseltamivir

KW - pediatric

KW - postexposure prophylaxis

KW - zanamivir

UR - http://www.scopus.com/inward/record.url?scp=84867868477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867868477&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e318260265a

DO - 10.1097/INF.0b013e318260265a

M3 - Article

VL - 31

SP - 1119

EP - 1123

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -